Sandilya edits Hormone Journal — independent, evidence-led coverage with verifiable sourcing and a transparent methodology.
Recent articles
- NewsEgg freezing surges in Canada: what PCOS patients need to know about fertility preservation options6 min read
- NewsWhat Canadian GLP-1 users need to know about 'Ozempic face' and emerging cosmetic treatments6 min read
- NewsWhat 'Ozempic face' means for Canadian GLP-1 users: why beauty companies are racing to fix it6 min read
- NewsNew small-molecule GLP-1 drug shows cardiovascular safety: what it means for Canadian PCOS and weight-loss patients6 min read
- NewsNew small-molecule GLP-1 drug orforglipron shows cardiovascular safety: what it means for Canadian weight-loss and diabetes patients6 min read
- NewsNew study links menopause hormone therapy to increased migraine burden: what Canadian patients should know6 min read
- NewsGLP-1 drugs may slow aging, raising questions about Canadian access and coverage6 min read
- NewsTriple-agonist retatrutide shows promise for weight loss in type 2 diabetes: what Canadian patients should know6 min read
- NewsNew study shows combined estrogen-testosterone therapy boosts bone density: what it means for Canadian menopause patients6 min read
- NewsNew study: HRT may boost GLP-1 weight loss results — what Canadian patients should know5 min read
- NewsWHO approves GLP-1s for some obese youth: what Canadian clinicians and PCOS patients need to know6 min read
- NewsWHO endorses GLP-1s for some obese youth: what Canada's regulators and clinicians need to know6 min read
- NewsHow Canadian GLP-1 users are adapting Thanksgiving meals: smaller portions, earlier dinners, recipe tweaks6 min read
- NewsGLP-1 drugs in Canadian children: what emerging safety data means for pediatric obesity care6 min read
- NewsNovo Nordisk's oral semaglutide (Wegovy pill) shows greater weight loss than injections in real-world data: what does it mean for Canadian GLP-1 patients?6 min read
- LaunchesGLP-1 drug costs surge in Canada: what private insurance data reveals about access gaps6 min read
- NewsWhy Canadian doctors are cautious about testosterone for menopause and what the science actually shows6 min read
- NewsWhy Canadian women are turning to testosterone for menopause and what the evidence actually shows6 min read
- NewsHealth Canada warns of counterfeit Soprano laser devices in Canadian clinics: what patients should know6 min read
- NewsBMJ study compares kidney safety of GLP-1 and SGLT-2 drugs in type 2 diabetes: what Canadian patients on weight-loss medications should know8 min read
- NewsUK GPs told to halt semaglutide prescribing without funding guarantee: what this signals for Canadian access6 min read
- NewsNew study: hormone therapy may reduce mood disturbances in menopause — what Canadian patients should know6 min read
- NewsHRT claims among Canadian working women surge 228% in five years: what's driving the shift?7 min read
- NewsNew ENDO 2026 data: menopausal hormone therapy cuts low bone-density risk by 69% — what Canadian patients should know6 min read
- NewsNew study: over half of Canadians who stop GLP-1 weight-loss drugs restart within a year — what it means for your treatment plan6 min read
- NewsNew data on GLP-1 restart patterns: what Canadian patients should know about stopping and restarting weight-loss medications6 min read
- NewsEarly menopause linked to high blood pressure: what Canadian patients need to know about cardiovascular screening6 min read
- NewsBMJ study confirms hair loss risk with GLP-1 drugs: what Canadian patients should know6 min read
- NewsGLP-1 weight-loss drugs linked to hair loss: what Canadian patients need to know6 min read
- NewsUK regulator flags domperidone safety risk: Canadian patients and clinicians should watch for Health Canada update6 min read
- NewsGLP-1 drugs show promise for binge eating disorder: what Canadian patients should know6 min read
- NewsHealth Canada speeds up drug approvals: what it means for hormone-therapy access6 min read
- NewsHealth Canada approves 15 new drugs in Q2 2026: what hormone patients need to know5 min read
- NewsOne-third of women confused about perimenopause: what Canadian patients need to know6 min read
- NewsCMAJ study: combining GLP-1 drugs with SGLT2 inhibitors shows stronger heart failure protection than either alone7 min read
- NewsHealth Canada halts new prescriptions of TAVNEOS over trial-data integrity concerns6 min read
- NewsPCOS renamed to PMOS: what the global nomenclature shift means for Canadian patients and clinicians6 min read
- NewsPCOS renamed to PMOS: what the global nomenclature shift means for Canadian patients6 min read
- NewsHealth Canada approves first generic semaglutide injection for weight loss: what it means for Canadian patients6 min read
- NewsNew study links GLP-1 drugs to smell and taste loss: what Canadian weight-loss patients should know6 min read
- NewsNew study: Canadian women on hormone therapy show healthier diet, activity, and sleep patterns6 min read
- NewsNEJM updates thyroid cancer management: what Canadian endocrinologists and patients need to know6 min read
- NewsGLP-1 weight-loss drugs may boost testosterone and sperm count in men, new research suggests6 min read
- NewsNew study: surgical menopause linked to more severe genitourinary symptoms — what Canadian patients should know6 min read
- NewsAstraZeneca's oral GLP-1 pill shows weight-loss results comparable to Ozempic and Wegovy — what does it mean for Canadian access?6 min read
- NewsAstraZeneca's oral GLP-1 pill shows weight-loss promise: what Canadian patients need to know5 min read
- NewsOsteoporosis Canada warns GLP-1 users about bone-health risks: what Canadian patients need to know6 min read
- NewsStudy links endometriosis and infertility to early menopause risk: what Canadian patients should know7 min read
- NewsGLP-1 'microdosing' for weight loss lacks evidence—what Canadian patients should know6 min read
- LaunchesFelix Health launches generic semaglutide across Canada: what it means for GLP-1 access and cost6 min read